Grand Pharmaceutical Group Limited (HKG:0512)
Hong Kong · Delayed Price · Currency is HKD 9.23
+0.02 (0.22%)
Sep 3, 2025, 11:44 AM HKT
HKG:0512 Market Cap
HKG:0512 has a market cap or net worth of 32.25 billion as of September 2, 2025. Its market cap has increased by 103.76% in one year.
Market Cap
32.25B
Enterprise Value
34.66B
Revenue
11.70B
Ranking
n/a
PE Ratio
15.50
Stock Price
9.23
Market Cap Chart
Since February 28, 1996, HKG:0512's market cap has increased from 1.42B to 32.25B, an increase of 2,164.91%. That is a compound annual growth rate of 11.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2025 | 32.25B | 91.88% |
| Dec 31, 2024 | 16.81B | 16.78% |
| Dec 29, 2023 | 14.39B | -11.29% |
| Dec 30, 2022 | 16.22B | -29.24% |
| Dec 31, 2021 | 22.93B | -6.10% |
| Dec 31, 2020 | 24.42B | 70.53% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines | 262.49B |
| Hansoh Pharmaceutical Group Company | 218.06B |
| JD Health International | 205.21B |
| Innovent Biologics | 165.88B |
| Sino Biopharmaceutical | 145.04B |
| Akeso | 139.76B |
| WuXi Biologics | 135.14B |
| CSPC Pharmaceutical Group | 115.13B |